1. Satb2 regulates proliferation and nuclear integrity of pre-osteoblasts
- Author
-
Todd Dowrey, Jennifer L. Fish, Yuri A. Zarate, Fjodor Merkuri, Evelyn E. Schwager, and Julieann Duong
- Subjects
0301 basic medicine ,Cell Nucleus Shape ,Histology ,Physiology ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Biology ,Models, Biological ,Article ,Cell Line ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Osteogenesis ,Animals ,Scaffold/matrix attachment region ,Transcription factor ,Gene ,Cell Proliferation ,030304 developmental biology ,Cell Nucleus ,0303 health sciences ,Osteoblasts ,Binding protein ,Cell Cycle ,DNA replication ,Cell Differentiation ,Matrix Attachment Region Binding Proteins ,Phenotype ,Chromatin ,Cell biology ,030104 developmental biology ,Gene Expression Regulation ,Apoptosis ,Mutation ,CRISPR-Cas Systems ,030217 neurology & neurosurgery ,Transcription Factors - Abstract
Special AT-rich sequence binding protein 2 (Satb2) is a matrix attachment region (MAR) binding protein. Satb2 impacts skeletal development by regulating gene transcription required for osteogenic differentiation. Although its role as a high-order transcription factor is well supported, other roles for Satb2 in skeletal development remain unclear. In particular, the impact of dosage sensitivity (heterozygous mutations) and variance on phenotypic severity is still not well understood. To further investigate molecular and cellular mechanisms of Satb2-mediated skeletal defects, we used the CRISPR/Cas9 system to generateSatb2mutations in MC3T3-E1 cells. Our data suggest that, in addition to its role in differentiation, Satb2 regulates progenitor proliferation. We also find that mutations inSatb2cause chromatin defects including nuclear blebbing and donut-shaped nuclei. These defects may contribute to a slight increase in apoptosis in mutant cells, but apoptosis is insufficient to explain the proliferation defects.Satb2expression exhibits population-level variation and is mostly highly expressed from late G1 to late G2. Based on these data, we hypothesize that Satb2 may regulate proliferation through two separate mechanisms. First, Satb2 may regulate the expression of genes necessary for cell cycle progression in pre-osteoblasts. Second, similar to other MAR-binding proteins, Satb2 may participate in DNA replication. Deficiencies in either of these processes could reduce the pace of cell cycle progression and contribute to nuclear damage. We also hypothesize that Satb2-mediated proliferation defects may be buffered in some genetic backgrounds, which provides some explanation for differences in severity of skeletal defects. Further elucidation of the role of Satb2 in proliferation has potential impacts on our understanding of both skeletal defects and cancer.
- Published
- 2019
- Full Text
- View/download PDF